Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer

Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer

10/15/2012 10:17:24 AM

WILMINGTON, N.C.--Osmotica Pharmaceutical Corp. today announced the appointment of Dr. Praveen Tyle as Executive Vice President and Chief Scientific Officer. He also serves as the Managing Director of Osmotica's Marietta, Georgia site. Forrest Waldon, CEO of Osmotica Pharmaceutical stated, "We are pleased to announce that Praveen Tyle has joined Osmotica as Chief Science Officer and Executive Vice President. Praveen is a proven industry veteran with an impressive record of moving pharmaceutical pipelines to commercial success."

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.